Related Experiment Video
Updated: Jul 16, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Meningococcemia: epidemiology, pathophysiology, and management
1Critical Care Services, Children's Medical Center Dallas, 1935 Motor Street, Dallas, TX 75235, USA. lisa.milonovich@childrens.com
Insights
Prompt recognition and aggressive treatment are crucial for survival in pediatric meningococcemia, a severe Neisseria meningitidis infection. Ongoing research aims to improve outcomes for this devastating disease.
Area of Science:
- Pediatric Infectious Diseases
- Critical Care Medicine
- Bacteriology
Background:
- Meningococcemia, caused by Neisseria meningitidis, is a rare but severe infection primarily affecting children.
- Neisseria meningitidis exhibits high virulence, necessitating rapid diagnosis and intervention to mitigate severe outcomes.
- Managing pediatric meningococcemia in the intensive care unit presents significant challenges, demanding specialized expertise and advanced resources.
Purpose of the Study:
- To highlight the critical importance of early detection and management of meningococcemia in pediatric patients.
- To underscore the challenges associated with treating severe meningococcal infections in a pediatric intensive care setting.
- To emphasize the current limitations and future directions in meningococcemia research and therapy.
Main Methods:
- This abstract summarizes current understanding and clinical approaches to meningococcemia.
- It reviews the high virulence of Neisseria meningitidis compared to other Gram-negative bacteria.
- It discusses the essential components for managing affected children in a pediatric intensive care unit.
Main Results:
- Prompt recognition of meningococcemia signs and symptoms is vital for patient survival.
- Aggressive treatment strategies are currently the most effective approach to managing the disease.
- Despite research efforts, prompt clinical intervention remains the cornerstone of improving survival rates.
Conclusions:
- Early identification and immediate, aggressive treatment are paramount for improving survival in pediatric meningococcemia.
- While novel therapies are under investigation, current management relies heavily on prompt clinical recognition and intervention.
- The high virulence of Neisseria meningitidis underscores the need for continued research into more effective treatments to reduce morbidity and mortality.
Abstract:
Meningococcemia is a rare but devastating disease that affects primarily the pediatric population. The virulence of Neisseria meningitidis is 100 times that of other gram-negative organisms, making prompt recognition and treatment essential to prevent significant morbidity and mortality. Management of these patients in the pediatric intensive care unit is a challenge and requires skilled clinicians, high level technology, and novel therapies. Research into more effective treatment for meningococcemia continues in hopes of improving mortality and decreasing morbidity associated with this disease; however, thus far, prompt recognition of the signs and symptoms and aggressive treatment remain the mainstay of survival.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:26Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Cryptococcal Meningitis
Bacterial Meningitis
Viral Meningitis
Brain Abscess l: Introduction